Biology of the blood-brain and "blood-brain tumor" barriers

Handbook of Brain Tumor Chemotherapy

Volumn , Issue , 2006, Pages 236-243

  Engelhard, Herbert H ^a   Valyi Nagy, Tibor ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884100172     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088410-0/50054-8     Document Type: Chapter

References (55)

1. Pardridge W.M. Advances in cell biology of blood-brain barrier transport. Semin Cell Biol 1991, 2:419-426.
2. Engelhard H.H. Brain tumors and the blood-brain barrier. Neuro-Oncology: The Essentials 2000, 49-53. Thieme. M. Bernstein, M. Berger (Eds.).
3. Barshes N., Demopoulos A., Engelhard H.H. Anatomy and physiology of the leptomeninges and CSF space. Leptomeningeal Cancer 2005, Norwell, Kluwer Academic Publishers, New York. L. Abrey, M.C. Chamberlain, H.H. Engelhard (Eds.).
4. Nabeshima S., Reese T.S., Landis D.M.D., Brightman M.W. Junctions in the meninges and marginal glia. J Comp Neur 1975, 164:127-134.
5. Zinke H., Mockel B., Frey A., Weiler-Guttler H., Meckelein B., Gassen H.G. Blood-brain Barrier: A molecular approach to its structural and functional characterization. Progress in Brain Research 91 1992, 103-116. Elsevier Science Publishers, Massachusetts. A. Ermisch, R. Landgraf, H.J. Ruhle (Eds.).
6. Greig N.H. Brain tumors and the blood-tumor barrier. Implications of the Blood-brain Barrier and Its Manipulation 1989, Vol. 2:77-106. Plenum Medical Book Co. E.A. Neuwelt (Ed.).
7. Engelhard H.H., Groothuis D.G. The blood-brain barrier: Structure, function and response to neoplasia. The Gliomas 1998, 115-121. W. B. Saunders Co., New York. M. Berger, C. Wilson (Eds.).
8. DeBoer A.G., Breimer D.D. The blood-brain barrier: Clinical implications for drug delivery to the brain. J Royal College Physicians London 1994, 28:502-506.
9. Neuwelt E.A. Mechanisms of disease: the blood-brain barrier. Neurosurgery 2004, 54:141-142.
10. Abbott N.J., Revest P.A., Romero I.A. Astrocyteendothelial interaction: physiology and pathology. Neuropath Appl Neurobiol 1992, 18:424-433.
11. Abbott N.J. Dynamics of CNS barriers: Evolution, differentiation, and modulation. Cell Mol Neurobiol 2005, 25:5-23.
12. Wolburg H., Lippoldt A. Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul Pharmacol 2002, 38:323-337.
13. Vorbrodt A.W., Dobrogowska D.H. Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: electron microscopist's view. Brain Res Brain Res Rev 2003, 42:221-242.
14. Risau W. Molecular biology of blood-brain barrier ontogenesis and function. Acta Neurochir (Wien) 1994, 60:109-112. Suppl.
15. DeVries H.E., Montagne L., Dijkstra C.D., van der Valk P. Molecular and cellular biology of the blood-brain barrier and its characteristics in brain tumors. Contemporary Cancer Research: Brain Tumors 2004, 157-174. Humana Press, Philadelphia. F. Ali-Osman (Ed.).
16. Milhorat T.H. The third circulation revisited. J Neurosurg 1975, 42:628-645.
17. Prieto M., Chauvet N., Alonso G. Tanycytes transplanted into the adult rat spinal cord support the regeneration of lesioned axons. Exp Neurol 2000, 161:27-37.
18. Pardridge W.M. Blood-brain barrier transport of nutrients. Fed. Proc 1986, 45:2047-2049.
19. Salcman M., Broadwell R.D. The blood-brain barrier. Neurobiology of Brain Tumors 1991, 229-249. Williams & Wilkins, New Jersey, Totowa. M. Salcman (Ed.).
20. Allen D.D., Lockman P.R. The blood-brain barrier choline transporter as a brain drug delivery vector. Life Sci 2003, 73:1609-1615.
21. GraffC.L., Pollack G.M. Drug transport at the blood-brain barrier and the choroid plexus. Cur Drug Metab 2004, 5:95-108.
22. Shah G.N., Mooradian A.D. Age-related changes in the blood-brain barrier. Experimental Gerontology 1997, 32:501-519.
23. Sun H., Dai H., Shaik N., Elmquist W.F. Drug efflux transporters in the CNS. Adv Drug Deliv Rev 2003, 55:83-105.
24. Regina A., Demeule M., Laplante A., et al. Multidrug resistance in brain tumors: roles of the blood-brain barrier. Cancer Metastasis Rev 2001, 20:13-25.
25. Bart J., Groen H.J., Hendrikse N.H., et al. The blood-brain barrier and oncology: New insights into function and modulation. Cancer Treat Rev 2000, 26:449-462.
26. Hosoya K., Ohtsuki S., Terasaki T. Recent advances in the brain-to-blood efflux transport across the blood-brain barrier. Int J Pharm 2002, 248:15-29.
27. Fishman R.A. Cerebrospinal Fluid in Diseases of the Nervous System 1992, W.B. Saunders Co., Baltimore.
28. Van Vulpen M., Kal H.B., Taphoorn M.J., El-Sharouni S.Y. Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy. Oncol Rep 2002, 9:683-688.
29. Fortin D. The blood-brain barrier should not be under-estimated in neuro-oncology. Revue Neurologique 2004, 160:523-532.
30. Kroll R.A., Neuwelt E.A. Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 1998, 42:1083-1099.
31. Waterhouse R.N. Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents. Mol Imaging Biol 2003, 5:376-389.
32. Engelhard H.H., Duncan H., Kim S., Criswell P.S., Van Eldik L. Therapeutic effects of sodium butyrate on glioma cells in vitro and in the rat C6 glioma model. Neurosurgery 2001, 48:616-625.
33. Groothuis D.R. The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery. Neuro-oncol 2000, 2:45-59.
34. Golden P.L., Pollack G.M. Blood-brain barrier efflux transport. J Pharm Sci 2003, 92:1739-1753.
35. Sun H., Dai H., Shaik N., Elmquist W.F. Drug efflux transporters in the CNS. Adv Drug Deliv Rev 2003, 55:83-105.
36. Kemper E.M., Boogerd W., Thuis I., et al. Modulation of the blood-brain barrier in oncology: Therapeutic opportunities for the treatment of brain tumors. Cancer Treat Rev 2004, 30:415-423.
37. Grabb P.A., Gilbert M.R. Neoplastic and pharmacological influence on the permeability of an in vitro blood-brain barrier. J Neurosurg 1995, 82:1053-1058.
38. Gratton J.A., Abraham M.H., Bradbury M.W., Chadha H.S. Molecular factors influencing drug transfer across the blood-brain barrier. J Pharm Pharmacol 1997, 49:1211-1216.
39. Chakrabarty S.P., Hanson F.B. Optimal Control of Drug Delivery to Brain Tumors for a Distributed Parameters Model. Proceedings of 2005 American Control Conference 2005, 1-6.
40. Dash A.K., Elmquist W.F. Separation methods that are capable of revealing blood-brain barrier permeability. J Chromatogr B Analyt Technol in the Biomed Life Sci 2003, 797:241-254.
41. DeAngelis L.M. Benefits of adjuvant chemotherapy in high-grade gliomas. Semin Oncol 2003, 30:15-18. (6 Suppl 19).
42. Schiffer D. Brain Tumors: Pathology and its Biological Correlates 1993, Springer-Verlag, Philadelphia.
43. Giese A., Westphal M. Glioma invasion in the central nervous system. Neurosurgery 1996, 39:235-250.
44. Rapoport S.I. Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapy. Expert Opin on Investing Drugs 2001, 10:1809-1818.
45. Zunkuler B., Carson R.E., Olson J., et al. Quantification and pharmacokinetics of blood-brain barrier disruption in humans. J Neurosurg 1996, 85:1056-1065.
46. Doolittle N.D., Miner M.E., Hall W.A., et al. Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors. Cancer 2000, 88:637-647.
47. Cloughesy T.F., Black K.L. Pharmacological blood-brain barrier modification for selective drug delivery. J Neurooncol 1995, 26:125-132.
48. Dahlborg S.A., Henner W.D., Crossen J.R., et al. Non-AIDS primary CNS lymphoma: First example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy. Cancer J Sci Am 1996, 2:166.
49. Park D.M., Abrey L.E. Pharmacotherapy of primary CNS lymphoma. Expert Opin Pharmacother 2002, 3:39-49.
50. Plotkin S.R., Batchelor T.T. Primary central nervous system lymphoma. Curr Treatment Options Oncol 2002, 3:525-535.
51. Engelhard H. The role of interstitial BCNU chemotherapy in the treatment of malignant glioma. Surg Neurol 2000, 53:458-464.
52. Dunn I.F., Black P.M. The neurosurgeon as local oncologist: cellular and molecular neurosurgery in malignant glioma therapy. Neurosurgery 2003, 52:1411-1422.
53. Blomer U., Ganser A., Scherr M. Invasive drug delivery. Adv Exp Med Biol 2002, 513:431-451.
54. Bansal K., Engelhard H.H. Gene therapy for brain tumors. Cur Oncol Rep 2000, 2:463-472.
55. Engelhard H.H., Egli M., Rozental J. Use of antisense vectors and oligodeoxynucleotides in neurooncology. Pediatr Neurosurg 1998, 29:1-10.